UK markets open in 1 hour 13 minutes
NIKKEI 225
37,637.77 -822.31 (-2.14%) HANG SENG
17,276.95 +75.68 (+0.44%) CRUDE OIL
82.97 +0.16 (+0.19%) GOLD FUTURES
2,330.10 -8.30 (-0.35%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,560.39 -1,960.89 (-3.66%)
Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 53.34B |
| Enterprise value | 52.39B |
| Trailing P/E | 38.53 |
| Forward P/E | 32.36 |
| PEG ratio (5-yr expected) | 5.09 |
| Price/sales (ttm) | 8.99 |
| Price/book (mrq) | 8.02 |
| Enterprise value/revenue | 8.72 |
| Enterprise value/EBITDA | 29.76 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.07 |
| 52-week change 3 | 2.18% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 96.12 |
| 52-week low 3 | 60.57 |
| 50-day moving average 3 | 90.04 |
| 200-day moving average 3 | 78.71 |
Share statistics
| Avg vol (3-month) 3 | 3.98M |
| Avg vol (10-day) 3 | 2.93M |
| Shares outstanding 5 | 601.93M |
| Implied shares outstanding 6 | 601.93M |
| Float 8 | 595.33M |
| % held by insiders 1 | 0.89% |
| % held by institutions 1 | 84.05% |
| Shares short (15 Apr 2024) 4 | 7.38M |
| Short ratio (15 Apr 2024) 4 | 2.29 |
| Short % of float (15 Apr 2024) 4 | 1.24% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.23% |
| Shares short (prior month 15 Mar 2024) 4 | 10.45M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 01 Jun 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 23.35% |
| Operating margin (ttm) | 39.40% |
Management effectiveness
| Return on assets (ttm) | 12.25% |
| Return on equity (ttm) | 22.34% |
Income statement
| Revenue (ttm) | 6B |
| Revenue per share (ttm) | 9.90 |
| Quarterly revenue growth (yoy) | 13.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.87B |
| Net income avi to common (ttm) | 1.4B |
| Diluted EPS (ttm) | 2.30 |
| Quarterly earnings growth (yoy) | -7.20% |
Balance sheet
| Total cash (mrq) | 1.64B |
| Total cash per share (mrq) | 2.73 |
| Total debt (mrq) | 694.9M |
| Total debt/equity (mrq) | 10.34% |
| Current ratio (mrq) | 3.38 |
| Book value per share (mrq) | 11.06 |
Cash flow statement
| Operating cash flow (ttm) | 895.8M |
| Levered free cash flow (ttm) | 751.03M |
© 2024 Yahoo. All rights reserved.